CN102665684A - 用于吸入的组合物 - Google Patents

用于吸入的组合物 Download PDF

Info

Publication number
CN102665684A
CN102665684A CN2010800478259A CN201080047825A CN102665684A CN 102665684 A CN102665684 A CN 102665684A CN 2010800478259 A CN2010800478259 A CN 2010800478259A CN 201080047825 A CN201080047825 A CN 201080047825A CN 102665684 A CN102665684 A CN 102665684A
Authority
CN
China
Prior art keywords
calcium
composition
zinc
salt
metal ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800478259A
Other languages
English (en)
Chinese (zh)
Inventor
格伦·马丁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
Innovata Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovata Ltd filed Critical Innovata Ltd
Publication of CN102665684A publication Critical patent/CN102665684A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2010800478259A 2009-10-21 2010-10-21 用于吸入的组合物 Pending CN102665684A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0918450.8A GB0918450D0 (en) 2009-10-21 2009-10-21 Composition
GB0918450.8 2009-10-21
PCT/GB2010/001955 WO2011048379A2 (en) 2009-10-21 2010-10-21 Composition

Publications (1)

Publication Number Publication Date
CN102665684A true CN102665684A (zh) 2012-09-12

Family

ID=41426476

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800478259A Pending CN102665684A (zh) 2009-10-21 2010-10-21 用于吸入的组合物

Country Status (7)

Country Link
US (1) US20130004542A1 (enExample)
EP (1) EP2490670B1 (enExample)
JP (1) JP2013508344A (enExample)
CN (1) CN102665684A (enExample)
CA (1) CA2777899C (enExample)
GB (1) GB0918450D0 (enExample)
WO (1) WO2011048379A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113163843A (zh) * 2018-11-01 2021-07-23 尼科创业贸易有限公司 凝胶和结晶粉末
CN115046816A (zh) * 2022-03-11 2022-09-13 桂林优利特医疗电子有限公司 一种尿液有形成分分析仪用结晶质控物的制备方法

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
PT2410981T (pt) 2009-03-26 2017-05-25 Pulmatrix Inc Formulações em pó seco e métodos para tratar doenças pulmonares
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
AU2011296343B2 (en) 2010-08-30 2015-12-10 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
US20130164338A1 (en) 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
PT2621488T (pt) 2010-09-29 2019-02-12 Pulmatrix Operating Co Inc Pós secos catiónicos
CA3086367A1 (en) 2010-09-29 2012-04-05 Pulmatrix Operating Company, Inc. Monovalent metal cation dry powders for inhalation
WO2014007773A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and sorbitol
CN104487075A (zh) 2012-02-29 2015-04-01 普马特里克斯公司 可吸入干粉剂
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007768A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhaler compositions comprising long acting muscorinic antagonists
US20150174064A1 (en) * 2012-07-05 2015-06-25 Arven IIac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and glucose anhydrous
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
EA201591218A1 (ru) * 2012-12-27 2015-11-30 Майкродоуз Терапьютикс, Инк. Способы и композиции для введения оксибутинина
CN104885172B (zh) * 2012-12-27 2019-12-13 3M创新有限公司 电化学装置及其制造方法
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
JP2015116367A (ja) * 2013-12-19 2015-06-25 重人 下山 寝具装置、寝具装置制御方法及びプログラム
CN103830194A (zh) * 2014-03-11 2014-06-04 熊妲妮 茚达特罗固体分散体及含有其的药物组合物
CA2965759C (en) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
WO2017100656A1 (en) * 2015-12-11 2017-06-15 Otitopic Inc. Dry powder formulations of aspirin for inhalation
JP7334983B2 (ja) * 2018-01-11 2023-08-29 エンフィスィーマ ソリューションズ ベスローテン フェンノートシャップ 肺気腫及びその他の形態のｃｏｐｄの治療のための組成物及び方法
AU2022410611A1 (en) * 2021-12-16 2024-07-18 Alveolus Bio, Inc. Spray dried inhalable biotherapeutics for the treatment of disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016205A2 (en) * 1996-10-17 1998-04-23 Inhale Therapeutic Systems Stable glassy state powder formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8802174D0 (en) * 1988-02-01 1988-03-02 Quadrant Bioresources Ltd Method of drying macromolecules
WO1990011756A1 (en) 1989-04-12 1990-10-18 Aberdeen University Slow release vitreous systems
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
EP0563455A1 (en) 1992-03-31 1993-10-06 Purac Biochem B.V. Particulate solid products containing a lump forming inhibitor
ATE222754T1 (de) * 1992-06-12 2002-09-15 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
ATE264096T1 (de) 1994-03-07 2004-04-15 Nektar Therapeutics Verfahren und mittel zur verabreichung von insulin über die lunge
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
JP3095624B2 (ja) 1994-07-19 2000-10-10 株式会社ボッシュオートモーティブシステム 積層型熱交換器の偏平チューブのろう付け方法
FI970867A7 (fi) 1994-08-04 1997-04-08 Quadrant Drug Delivery Ltd Kiinteät, annostelusysteemit hallittua vapautumista varten, joihin sys teemeihin molekyylit on sisällytetty ja menetelmät niiden valmistamise ksi
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
CZ391297A3 (cs) 1995-06-07 1998-05-13 Quadrant Holdings Cambridge Limited Způsob přípravy tenké porovité skelné matrice a prostředek tím získaný
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
GB9621825D0 (en) 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
WO1999047174A1 (en) 1998-03-18 1999-09-23 Cambridge Biostability Limited Amorphous glasses for stabilising sensitive products
DK1131059T3 (da) 1998-11-13 2003-06-30 Jago Res Ag Tørpulver til inhalation
EP1158958B1 (en) 1999-03-05 2007-06-06 CHIESI FARMACEUTICI S.p.A. Improved powdery pharmaceutical compositions for inhalation
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10050995A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
DE10141376A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
JP2003062074A (ja) * 2001-08-29 2003-03-04 Tomohiko Hashiba 吸入装置
DE10203749A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203741A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203753A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
EP1480996A1 (en) * 2002-02-04 2004-12-01 Glaxo Group Limited Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
CA2478327A1 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Hgh (human growth hormone) formulations for pulmonary administration
AU2003291527A1 (en) 2002-12-31 2004-07-29 Nektar Therapeutics Antibody-containing particles and compositions
JP2005060330A (ja) * 2003-08-18 2005-03-10 Tomohiko Hashiba 球状タンパク質粉体とその製造方法
GB0520794D0 (en) * 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
PT2410981T (pt) * 2009-03-26 2017-05-25 Pulmatrix Inc Formulações em pó seco e métodos para tratar doenças pulmonares
US20120083531A1 (en) * 2009-03-26 2012-04-05 Clarke Robert W Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016205A2 (en) * 1996-10-17 1998-04-23 Inhale Therapeutic Systems Stable glassy state powder formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113163843A (zh) * 2018-11-01 2021-07-23 尼科创业贸易有限公司 凝胶和结晶粉末
CN115046816A (zh) * 2022-03-11 2022-09-13 桂林优利特医疗电子有限公司 一种尿液有形成分分析仪用结晶质控物的制备方法

Also Published As

Publication number Publication date
CA2777899C (en) 2016-03-29
GB0918450D0 (en) 2009-12-09
WO2011048379A3 (en) 2012-01-05
EP2490670A2 (en) 2012-08-29
WO2011048379A2 (en) 2011-04-28
JP2013508344A (ja) 2013-03-07
EP2490670B1 (en) 2019-04-17
CA2777899A1 (en) 2011-04-28
US20130004542A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
CN102665684A (zh) 用于吸入的组合物
ES3033142T3 (en) Dry powder formulation comprising a phosphodiesterase inhibitor
RS65494B1 (sr) Kombinacije antagonista muskarinskog receptora i agonista beta-2-adrenoreceptora
CA2803418A1 (en) Dry powder formulation comprising an antimuscarinic drug
JP2015519394A (ja) キシナホ酸サルメテロール、プロピオン酸フルチカゾンおよび臭化チオトロピウムを含む吸入製剤用ドライパウダー、ならびにその製造方法
US20040062719A1 (en) Particulate inhalation carrier
KR102330428B1 (ko) 흡입 제형용 건조 분말 및 이의 제조방법
CN105338967A (zh) 包含布地奈德和福莫特罗的药物组合物
EP2821062A1 (en) Novel dry powder inhaler formulations
CN111481550A (zh) 含有噻托溴铵和阿福特罗的药物制剂
KR102696616B1 (ko) 흡입 제형용 건조 분말 및 이의 제조방법
KR102898819B1 (ko) 흡입용 건조 분말 제제를 위한 신규 담체 입자
JP7712916B2 (ja) 吸入用乾燥粉末製剤のための新規担体粒子
RU2823554C1 (ru) Новые частицы носителя для сухих порошковых составов для ингаляции
RU2795231C2 (ru) Новые частицы носителя для сухих порошковых составов для ингаляции
HK40064779A (en) Novel carrier particles for dry powder formulations for inhalation
CN112469443A (zh) 用于吸入用干粉制剂的新型载体颗粒
HK40037203A (en) Novel carrier particles for dry powder formulations for inhalation
HK1239571A1 (en) Dry powder formulation comprising a phosphodiesterase inhibitor
TW201618759A (zh) 具有經改善之組合型活性成分之穩定性的吸入型調配物乾粉末
HK1182002A (en) Dry powder formulation comprising a phosphodiesterase inhibitor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20160203

C20 Patent right or utility model deemed to be abandoned or is abandoned